Financial Ratios

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - (AMALGAMATED)

NSE : NABSE : 500676ISIN CODE : INE264A01014Industry : Consumer FoodHouse : Glaxosmithkline - MNC
BSE10753.650 (0 %)
PREV CLOSE ( ) 10753.65
OPEN PRICE ( ) 10500.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2533
TODAY'S LOW / HIGH ( )10394.05 10845.75
52 WK LOW / HIGH ( ) 10394.0510845.75
NSE
This Company is not listed in NSE
Select year
ParticularsMar2019Mar2018Mar2017Mar2016Mar2015
Operational & Financial Ratios
   Earnings Per Share (Rs)233.69166.47156.15163.42138.77
   CEPS(Rs)248.08181.78171.41177.08153.53
   DPS(Rs)105.0075.0070.0070.0055.00
   Book NAV/Share(Rs)973.65828.70742.51665.48502.44
   Tax Rate(%)35.0134.8435.0134.9134.36
Margin Ratios
   Core EBITDA Margin(%)23.8620.1818.9418.3616.11
   EBIT Margin(%)31.6424.5922.8923.1819.64
   Pre Tax Margin(%)31.6224.5522.8323.1319.62
   PAT Margin (%)20.5515.9914.8415.0612.88
   Cash Profit Margin (%)21.8217.4716.2916.3214.25
Performance Ratios
   ROA(%)11.329.039.3811.1511.04
   ROE(%)25.9321.1922.1827.9929.73
   ROCE(%)39.9232.5434.1042.9845.33
   Asset Turnover(x)0.550.560.630.740.86
   Sales/Fixed Asset(x)7.106.847.385.604.73
   Working Capital/Sales(x)1.381.551.741.982.80
Efficiency Ratios
   Fixed Capital/Sales(x)0.140.150.140.180.21
   Receivable days25.3625.0127.8426.6924.68
   Inventory Days33.3936.3038.0537.1035.19
   Payable days311.14291.56287.70264.41221.35
Valuation Parameters
   PER(x)30.8636.6133.0436.9345.40
   PCE(x)29.0733.5330.1034.0841.03
   Price/Book(x)7.417.366.959.0712.54
   Yield(%)1.461.231.361.160.87
   EV/Net Sales(x)5.495.114.675.485.62
   EV/Core EBITDA(x)16.6719.3317.2820.3325.42
   EV/EBIT(x)17.3420.4818.3821.4327.19
   EV/CE(x)2.832.722.513.444.21
   M Cap / Sales6.345.945.446.146.15
Growth Ratio
   Net Sales Growth(%)10.788.15-3.51-3.98-11.52
   Core EBITDA Growth(%)37.945.88-3.4317.20-11.83
   EBIT Growth(%)40.576.24-4.2618.92-12.51
   PAT Growth(%)40.386.61-4.4517.77-13.51
   EPS Growth(%)40.386.61-4.4517.77-13.51
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)2.472.622.592.581.96
   Quick Ratio(x)2.272.392.312.261.68
   Interest Cover(x)1943.07530.19364.69464.161201.09
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.